復旦張江(01349.HK)公佈2020年度業績 建議派發股息每股0.05元
格隆匯 3 月 25日丨復旦張江(01349.HK)發佈截至2020年12月31日止年度的年度業績公吿,2020年度,集團實現收入約人民幣8.338億元;其中主營業務收入約達人民幣8.325億元(佔營業收入的99.84%),同比下降19%。集團主要產品艾拉®(鹽酸氨酮戊酸散,ALA)和裏葆多®(鹽酸多柔比星脂質體,Doxorubicin liposome)為集團營業收入做出很大貢獻,分別佔集團收入的36%和53%。集團2020年度的營業收入主要來自於醫療及診斷產品銷售收入。2019年度的主要收入來源與本年基本一致。
報吿期內因處於疫情管控期間,前往各地醫院及附屬科室就診的患者數量及就診頻率明顯低於正常水平。隨着國內疫情基本得到控制,藥品流通及醫院患者就診逐步恢復,集團各醫藥產品的出貨量及藥品終端使用量亦開始逐步恢復,但集團2020年度經營業績仍受到較大影響。
2020年度,集團淨利潤約為人民幣1.64億元,同比減少約26%。2020年度,集團淨利潤率為20%,2019年同期為21%。2020淨利潤率較低主要因為集團由於新冠的影響銷售收入下降,固定支出保持不變,研發投入增加,導致淨利潤率下降。2020年度,公司股東於合併財務報表中應占年度利潤約為人民幣1.65億元,比2019年同期下降28%。建議派發股息每股人民幣0.05元(含税),總計約人民幣5215萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.